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Risk assessment and intervention programs that target
treated but uncontrolled hypertensives can be expected to
yield substantial economic benefits in addition to pre-
venting cardiovascular morbidity and mortality.
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OBJECTIVES: To compare the long-term clinical and
economic outcomes of elderly (75 years) versus younger
acute coronary syndrome patients. METHODS: We used
the Duke Cardiovascular Databank to identify patients
with a recent (6 weeks) myocardial infarction or unsta-
ble angina, index cardiac cath between 1986 and 1997,
significant coronary artery disease (CAD), and no previ-
ous cardiac procedures. Follow-up extended through
1998. We modeled clinical events (death, MI, coronary
artery bypass graft surgery (CABG), percutaneous coro-
nary intervention (PCI), and other rehospitalizations) to
12 years for pts with censored follow-up. We modeled in-
patient and outpatient medical costs for all patients using
inpatient costs from the GUSTO IIb clinical trial and
other secondary data sources. RESULTS: Elderly (n 
1401) vs. younger (n  8475) patients were more likely
female (58% vs. 32%) and non-smokers (41% vs. 69%),
had greater history of congestive heart failure (25% vs.
14%) and cerebral vascular disease (17% vs. 9%), less
single vessel disease (30% vs. 46%) and more three vessel
disease (43% vs. 26%), and greater 30-day mortality
(9.8% vs. 3.2%). While median 12-year medical costs
were greater for younger ($57,475) than for elderly
($53,431) patients, mean survival was less for elderly pa-
tients (6.4 vs. 9.3 years) yielding greater costs per year of
survival ($8075 vs. $6037) for the elderly. CONCLU-
SIONS: CAD patients undergoing an initial cardiac cath
after age 75 represent a high-risk group undetected by
current CAD screening algorithms. These findings point
to the need for improved screening tools and disease
management strategies in high-risk, pre-CAD popula-
tions.
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OBJECTIVES: Stroke is the third leading cause of death
and a leading cause of disability. We determined inci-
dence, and total direct costs of stroke by stroke type, age
group, gender and race. METHODS: We used an inci-
dence approach and aggregate national data sources to
determine 1998 US direct medical cost of stroke from a
societal perspective. We modeled the disease from first
hospitalization to end of first year. A sensitivity analysis
varied prevalence and utilization of each cost factor
around a base case. RESULTS: The incidence of first
stroke is 232/100,000 population of which 82% are is-
chemic strokes. The total annual costs of a first time
stroke are $25.2 billion. The first hospitalization ac-
counts for 20% of costs but all hospitalizations together
in the first year account for the highest proportion of
costs (65%, $15.9 billion). Those with subarachnoid
hemorrhagic stroke ($18,461) had first hospitalization
costs per stay more than three times higher than ischemic
stroke ($5,417) and more than two times higher than in-
tracerebral hemorrhagic stroke ($7,709). Also high are
costs for chronic disability care, which are $5.5 billion,
primarily home care ($3.9 billion). Sensitivity analysis
showed a maximum variation in cost from $15.8 to
$35.8 billion when varying incidence estimates. CON-
CLUSION: The societal cost burden is quite high and
caused primarily by disability factors. Although ischemic
stroke accounts for the highest total costs due to its
higher incidence, subarachnoid hemorrhagic stroke ac-
counts for more deaths and much higher first hospitaliza-
tion costs. This study demonstrates a high combined
acute and chronic care burden for stroke patients.
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OBJECTIVES: The importance of subsequent events on
health care costs following acute myocardial infarction
(AMI). METHODS: Patients with AMI (first admission 
index) were identified from Massachusetts (MA) 1996/
1997 patient-level discharge databases. Secondary events
(i.e., AMI, angina, CABG, PTCA, coronary angiography,
ischemic stroke, TIA, other related cardiovascular condi-
tions) occurring within 12 months were assessed in terms
of hospital costs, length of stay, discharge disposition
and post-acute care costs. These data were supplemented
by five additional state databases, fee schedules, other
agency and survey data, and the literature. All costs are
reported in 1998 US dollars adjusted for medical infla-
tion and cost-to-charge ratios. Log transformation was
used to address highly skewed distributions. RESULTS:
Of the 8,037 MA AMI patients, 86% were discharged
alive, and 54% of them were readmitted for another
event, 49% more than once. Of those readmitted, 8.9%
were hospitalized for a second AMI, 1.4% for a stroke. A
second AMI increases the use of post-discharge formal
health care services (e.g., skilled nursing facility, rehabili-
tation, home health care) by 19% and a stroke by 52%.
